Executive Director of Intelligence & Innovation - Market Access at Bristol-Myers Squibb

Princeton, New Jersey, United States

Apply Now

Not SpecifiedCompensation

Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, Biotechnology, HealthcareIndustries

Requirements

Ability to serve as a thought leader and strategic advisor to senior leaders on trends and innovation in pricing and reimbursement/access
Expertise in proactively identifying and translating market insights into strategic perspectives and actionable recommendations
Proficiency in developing and implementing strategic thinking frameworks (e.g., scenario simulations, blind spot analysis)
Skills in ensuring timely dissemination and interpretation of pricing and market access trends via executive briefings
Capability to rapidly provide thorough, insightful analyses in response to senior leadership queries
Experience leading a dynamic team and overseeing systematic monitoring of market trends, competitor activities, and news
Ability to build and maintain prioritization frameworks for relevant trends/intelligence
Expertise in developing and maintaining systems for tracking and analyzing market developments (e.g., sources, tools, analytics, processes)
Skills in designing and maintaining an info-base on innovations, trends, and disruptions
Strong people management skills, including hiring, managing scope/capacity, and creating growth opportunities

Responsibilities

Serve as a thought leader and strategic advisor to senior leaders on trends and innovation in the pricing and reimbursement/access space
Proactively identify and translate market insights into strategic perspectives and actionable recommendations for senior leadership, including serving as an “early warning system” on opportunities/challenges and developing solutions with stakeholders
Develop and implement strategic thinking frameworks (e.g., scenario simulations, blind spot analysis) to develop strategic perspectives and interpret market access implications of landscape changes
Ensure timely and accurate dissemination and interpretation of relevant pricing and market access trends to internal teams (e.g., via executive briefings)
Rapidly provide thorough and insightful analyses and perspectives in response to specific queries, ensuring clarity and strategic relevance
Lead a dynamic team and oversee the systematic monitoring of market trends, competitor activities, and news within the global market access and pricing landscape
Build and maintain a prioritization framework to focus attention on the trends/intelligence areas most relevant for BMS’ current and future portfolio
Develop and maintain a robust system for tracking and analyzing market developments (e.g., sources, tools, analytics, processes)
Design and maintain an info-base of the latest innovations, trends, and disruptions to enable quick responses to specific queries
Manage and develop the I&I team, including hiring, managing team scope and capacity, and creating growth opportunities for all team members
Proactively incubate novel opportunities for BMS to experiment, innovate, and lead in market access, across payor/reimbursement models, value-based pricing, GTN management, contracting, customer engagement, and new channels

Skills

Market Access

Pricing Strategy

Health Systems Analytics

Intelligence Curation

Innovation Incubation

Digital Transformation

AI Solutions

Strategic Advisory

Thought Leadership

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free